Biosergen AS was established in 2004 in order to exploit inventions made at SINTEF and Norwegian University of Science and Technology (NTNU). The company is located in Trondheim, Norway, with its laboratory located in the modern Natural Sciences Building on the campus of the NTNU. Key employees have extensive experience in researching antibiotic-producing bacteria,successful track records in the genetic manipulation of bacteria, and broad knowledge in drug development.The current major owners of the company are Karolinska Development AB, Östersjöstiftelsen, and Sintef Venture II.